Miranda César de Araujo, Meletti José F A, Lima Laís H N, Marchi Evaldo
Faculdade de Medicina de Jundiaí, Disciplina de Anestesiologia, Jundiaí, SP, Brasil.
Faculdade de Medicina de Jundiaí, Disciplina de Anestesiologia, Jundiaí, SP, Brasil.
Braz J Anesthesiol. 2020 Sep-Oct;70(5):484-490. doi: 10.1016/j.bjan.2020.04.014. Epub 2020 Jul 18.
Cardiac surgery can produce persistent deficit in the ratio of Oxygen Delivery (DO) to Oxygen Consumption (VO). Central venous oxygen Saturation (ScvO) is an accessible and indirect measure of DO/VO ratio.
To monitor perioperative ScvO and assess its correlation with mortality during cardiac surgery.
This prospective observational study evaluated 273 patients undergoing cardiac surgery. Blood gas samples were collected to measure ScvO at three time points: T0 (after anesthetic induction), T1 (end of surgery), and T2 (24 hours after surgery). The patients were divided into two groups (survivors and nonsurvivors). The following outcomes were analyzed: intrahospital mortality, length of Intensive Care Unit (ICU) and hospital stay (LOS), and variation in ScvO.
Of the 273 patients, 251 (92%) survived and 22 (8%) did not. There was a significant perioperative reduction of ScvO in both survivors (T0 = 78% ± 8.1%, T1 = 75.4% ± 7.5%, and T2 = 68.5% ± 9%; < 0.001) and nonsurvivors (T0 = 74.4% ± 8.7%, T1 = 75.4% ± 7.7%, and T2 = 66.7% ± 13.1%; < 0.001). At T0, the percentage of patients with ScvO< 70% was greater in the nonsurvivor group (31.8% vs. 13.1%; = 0.046) and the multiple logistic regression showed that ScvO is an independent risk factor associated with death, OR = 2.94 (95% CI 1.10−7.89) ( = 0.032). The length of ICU and LOS were 3.6 ± 3.1 and 7.4 ± 6.0 days respectively and was not significantly associated with ScvO.
Early intraoperative ScvO < 70% indicated a higher risk of death. A perioperative reduction of ScvO was observed in patients undergoing cardiac surgery, with high intraoperative and lower postoperative levels.
心脏手术可导致氧输送(DO)与氧消耗(VO)比值持续下降。中心静脉血氧饱和度(ScvO)是一种可获取的间接测量DO/VO比值的指标。
监测心脏手术围术期ScvO,并评估其与死亡率的相关性。
这项前瞻性观察性研究评估了273例接受心脏手术的患者。在三个时间点采集血气样本以测量ScvO:T0(麻醉诱导后)、T1(手术结束时)和T2(术后24小时)。患者被分为两组(存活者和非存活者)。分析以下结局:院内死亡率、重症监护病房(ICU)住院时间和住院时长(LOS)以及ScvO的变化。
273例患者中,251例(92%)存活,22例(8%)未存活。存活者(T0 = 78% ± 8.1%,T1 = 75.4% ± 7.5%,T2 = 68.5% ± 9%;P < 0.001)和非存活者(T0 = 74.4% ± 8.7%,T1 = 75.4% ± 7.7%,T2 = 66.7% ± 13.1%;P < 0.001)围术期ScvO均显著降低。在T0时,非存活者组ScvO < 70%的患者百分比更高(31.8%对13.1%;P = 0.046),多因素逻辑回归显示ScvO是与死亡相关的独立危险因素,比值比(OR)= 2.94(95%置信区间1.10 - 7.89)(P = 0.032)。ICU住院时间和LOS分别为3.6 ± 3.1天和7.4 ± 6.0天,且与ScvO无显著相关性。
术中早期ScvO < 70%表明死亡风险较高。接受心脏手术的患者围术期ScvO降低,术中水平较高而术后水平较低。